Oncosec Medical (ONCS) Prices 4.60M Share Common Offering at $3.25/Sh

OncoSec Medical Incorporated (NASDAQ: ONCS) today announced that in connection with its previously announced offering of common stock, it has entered into purchase agreements for the purchase of an aggregate 4,608,589 shares of the Company at an offering price of $3.25 per share for aggregate gross proceeds of approximately $15 million, before placement agent fees and other offering expenses. The offering is expected to close on or about August 19, 2020.

The Company intends to use the net proceeds from this offering for clinical, regulatory, manufacturing and, if and when approved, potential commercial activities of its product candidates; research and development activities, including potential acquisitions and in-licensing; and other general corporate purposes.

ThinkEquity, a division of Fordham Financial Management, Inc., and Torreya Capital, LLC are acting as the exclusive placement agents for the offering.

You May Also Be Interested In

• Qualcomm files to resell 17.8M shares tied to Modular acquisition
• Quince Therapeutics (QNCX) files for 15.47M share offering by selling stockholders
• Beyond Air prices private placement at up to $30.1M